388 related articles for article (PubMed ID: 6418807)
1. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
2. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
4. Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5.
Karr RW; Kannapell CC; Stein JA; Gebel HM; Mann DL; Duquesnoy RJ; Fuller TC; Rodey GE; Schwartz BD
J Immunol; 1982 Apr; 128(4):1809-18. PubMed ID: 6174616
[TBL] [Abstract][Full Text] [Related]
5. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
6. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
7. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
Matsuyama T; Schwenzer J; Silver J; Winchester R
J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
[TBL] [Abstract][Full Text] [Related]
8. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
[TBL] [Abstract][Full Text] [Related]
9. Human B cell alloantigens: expression of MB and MT determinants.
Markert ML; Cresswell P
J Immunol; 1982 May; 128(5):2004-8. PubMed ID: 6174619
[TBL] [Abstract][Full Text] [Related]
10. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
11. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
[TBL] [Abstract][Full Text] [Related]
12. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
[TBL] [Abstract][Full Text] [Related]
13. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.
Karr RW; Alber C; Goyert SM; Silver J; Duquesnoy RJ
J Exp Med; 1984 May; 159(5):1512-31. PubMed ID: 6425448
[TBL] [Abstract][Full Text] [Related]
14. Primary structural variation among serologically indistinguishable DS antigens: the MB3-bearing molecule in DR4 cells differs from the MB3-bearing molecule in DR5 cells.
Giles RC; Hurley CK; Capra JD
J Immunol; 1984 Jul; 133(1):1-3. PubMed ID: 6609970
[TBL] [Abstract][Full Text] [Related]
15. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet.
Bontrop RE; Schreuder GM; Elferink DG; Mikulski MM; Geerse R; Giphart MJ
J Immunol; 1986 Jul; 137(1):211-6. PubMed ID: 3486913
[TBL] [Abstract][Full Text] [Related]
16. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
[TBL] [Abstract][Full Text] [Related]
17. HLA-DS molecules and their relation to supertypic specificities.
Goyert SM; Moriuchi J; Winchester R; Silver J
Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
[TBL] [Abstract][Full Text] [Related]
18. Functional and molecular analysis of three distinct HLA-DR4 beta-chains responsible for the MLR between HLA-Dw4, Dw15, and DKT2.
Hirayama K; Nishimura Y; Tsukamoto K; Sasazuki T
J Immunol; 1986 Aug; 137(3):924-33. PubMed ID: 2424990
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of structural polymorphism among MB3 light chains by two-dimensional gel electrophoresis.
Ishikawa N; Kasahara M; Ikeda H; Ogasawara K; Hawkin S; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
J Immunol; 1985 Jan; 134(1):417-22. PubMed ID: 3871113
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms within the HLA-DR4 haplotypes. Various DQ subtypes detected with monoclonal antibodies.
Bontrop RE; Schreuder GM; Mikulski EM; van Miltenburg RT; Giphart MJ
Tissue Antigens; 1986 Jan; 27(1):22-31. PubMed ID: 3006281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
